top
Search terms
Results 1 - 1 of 1 - ordered by :
Escardio

Thrombin activatable fibrinolysis inhibitor promotes development of chronic thromboembolic pulmonary hypertension -A possible novel therapeutic target- Awardees 2016 Erik Klok (Vienna, AT), for its ...

Date : 01/09/2015